163 related articles for article (PubMed ID: 34534596)
1. Dopaminergic but not cholinergic neurodegeneration is correlated with gait disturbances in PINK1 knockout rats.
DeAngelo VM; Hilliard JD; McConnell GC
Behav Brain Res; 2022 Jan; 417():113575. PubMed ID: 34534596
[TBL] [Abstract][Full Text] [Related]
2. Pedunculopontine cell loss and protein aggregation direct microglia activation in parkinsonian rats.
Elson JL; Yates A; Pienaar IS
Brain Struct Funct; 2016 May; 221(4):2319-41. PubMed ID: 25989851
[TBL] [Abstract][Full Text] [Related]
3. Selective cholinergic depletion of pedunculopontine tegmental nucleus aggravates freezing of gait in parkinsonian rats.
Xiao H; Li M; Cai J; Li N; Zhou M; Wen P; Xie Z; Wang Q; Chang J; Zhang W
Neurosci Lett; 2017 Oct; 659():92-98. PubMed ID: 28803956
[TBL] [Abstract][Full Text] [Related]
4. The hTH-GFP reporter rat model for the study of Parkinson's disease.
Iacovitti L; Wei X; Cai J; Kostuk EW; Lin R; Gorodinsky A; Roman P; Kusek G; Das SS; Dufour A; Martinez TN; Dave KD
PLoS One; 2014; 9(12):e113151. PubMed ID: 25462571
[TBL] [Abstract][Full Text] [Related]
5. Unraveling a new circuitry for sleep regulation in Parkinson's disease.
Targa AD; Rodrigues LS; Noseda AC; Aurich MF; Andersen ML; Tufik S; da Cunha C; Lima MM
Neuropharmacology; 2016 Sep; 108():161-71. PubMed ID: 27091486
[TBL] [Abstract][Full Text] [Related]
6. Applying the RatWalker System for Gait Analysis in a Genetic Rat Model of Parkinson's Disease.
Stauch KL; Totusek S; Farmer T; Lamberty BG; Dyball KN; Almikhlafi MA; Fox HS
J Vis Exp; 2021 Jan; (167):. PubMed ID: 33522500
[TBL] [Abstract][Full Text] [Related]
7. DREADD Activation of Pedunculopontine Cholinergic Neurons Reverses Motor Deficits and Restores Striatal Dopamine Signaling in Parkinsonian Rats.
Sharma PK; Wells L; Rizzo G; Elson JL; Passchier J; Rabiner EA; Gunn RN; Dexter DT; Pienaar IS
Neurotherapeutics; 2020 Jul; 17(3):1120-1141. PubMed ID: 31965550
[TBL] [Abstract][Full Text] [Related]
8. Anesthetic Effects on the Progression of Parkinson Disease in the Rat DJ-1 Model.
Xu DA; DeYoung TP; Kondoleon NP; Eckenhoff RG; Eckenhoff MF
Anesth Analg; 2021 Nov; 133(5):1140-1151. PubMed ID: 34673725
[TBL] [Abstract][Full Text] [Related]
9. RGS Proteins as Critical Regulators of Motor Function and Their Implications in Parkinson's Disease.
Ahlers-Dannen KE; Spicer MM; Fisher RA
Mol Pharmacol; 2020 Dec; 98(6):730-738. PubMed ID: 32015009
[TBL] [Abstract][Full Text] [Related]
10. Early signs of neuronal apoptosis in the substantia nigra pars compacta of the progressive neurodegenerative mouse 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine/probenecid model of Parkinson's disease.
Novikova L; Garris BL; Garris DR; Lau YS
Neuroscience; 2006 Jun; 140(1):67-76. PubMed ID: 16533572
[TBL] [Abstract][Full Text] [Related]
11. Temporal-Spatial Profiling of Pedunculopontine Galanin-Cholinergic Neurons in the Lactacystin Rat Model of Parkinson's Disease.
Elson JL; Kochaj R; Reynolds R; Pienaar IS
Neurotox Res; 2018 Jul; 34(1):16-31. PubMed ID: 29218504
[TBL] [Abstract][Full Text] [Related]
12. Voluntary Physical Exercise Improves Subsequent Motor and Cognitive Impairments in a Rat Model of Parkinson's Disease.
Hsueh SC; Chen KY; Lai JH; Wu CC; Yu YW; Luo Y; Hsieh TH; Chiang YH
Int J Mol Sci; 2018 Feb; 19(2):. PubMed ID: 29419747
[TBL] [Abstract][Full Text] [Related]
13. An animal model mimicking pedunculopontine nucleus cholinergic degeneration in Parkinson's disease.
Pienaar IS; Harrison IF; Elson JL; Bury A; Woll P; Simon AK; Dexter DT
Brain Struct Funct; 2015 Jan; 220(1):479-500. PubMed ID: 24292256
[TBL] [Abstract][Full Text] [Related]
14. Quantitative assessment of gait and neurochemical correlation in a classical murine model of Parkinson's disease.
Wang XH; Lu G; Hu X; Tsang KS; Kwong WH; Wu FX; Meng HW; Jiang S; Liu SW; Ng HK; Poon WS
BMC Neurosci; 2012 Nov; 13():142. PubMed ID: 23151254
[TBL] [Abstract][Full Text] [Related]
15. Chronic restraint stress triggers dopaminergic and noradrenergic neurodegeneration: Possible role of chronic stress in the onset of Parkinson's disease.
Sugama S; Sekiyama K; Kodama T; Takamatsu Y; Takenouchi T; Hashimoto M; Bruno C; Kakinuma Y
Brain Behav Immun; 2016 Jan; 51():39-46. PubMed ID: 26291405
[TBL] [Abstract][Full Text] [Related]
16. Ursolic acid attenuates oxidative stress in nigrostriatal tissue and improves neurobehavioral activity in MPTP-induced Parkinsonian mouse model.
Rai SN; Yadav SK; Singh D; Singh SP
J Chem Neuroanat; 2016 Jan; 71():41-9. PubMed ID: 26686287
[TBL] [Abstract][Full Text] [Related]
17. Depopulation of dense α-synuclein aggregates is associated with rescue of dopamine neuron dysfunction and death in a new Parkinson's disease model.
Wegrzynowicz M; Bar-On D; Calo' L; Anichtchik O; Iovino M; Xia J; Ryazanov S; Leonov A; Giese A; Dalley JW; Griesinger C; Ashery U; Spillantini MG
Acta Neuropathol; 2019 Oct; 138(4):575-595. PubMed ID: 31165254
[TBL] [Abstract][Full Text] [Related]
18. A non-cholinergic neuronal loss in the pedunculopontine nucleus of toxin-evoked parkinsonian rats.
Pienaar IS; van de Berg W
Exp Neurol; 2013 Oct; 248():213-23. PubMed ID: 23769975
[TBL] [Abstract][Full Text] [Related]
19. Neuroprotective effect of curcumin-I in copper-induced dopaminergic neurotoxicity in rats: A possible link with Parkinson's disease.
Abbaoui A; Chatoui H; El Hiba O; Gamrani H
Neurosci Lett; 2017 Nov; 660():103-108. PubMed ID: 28919537
[TBL] [Abstract][Full Text] [Related]
20. The Neuroprotective Effects of GPR4 Inhibition through the Attenuation of Caspase Mediated Apoptotic Cell Death in an MPTP Induced Mouse Model of Parkinson's Disease.
Haque ME; Azam S; Akther M; Cho DY; Kim IS; Choi DK
Int J Mol Sci; 2021 Apr; 22(9):. PubMed ID: 33925146
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]